{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:02:19Z","timestamp":1789502539295,"version":"build-2803163510"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The study was supported by the Medical Health Science and Technology Project of Zhejiang Province","award":["2024KY1608"],"award-info":[{"award-number":["2024KY1608"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    The lifespan of people living with human immunodeficiency virus (PLWH) has been extended following antiretroviral therapy, which, paradoxically, has increased the burden of metabolic syndrome (MS). Asprosin has emerged as a novel biomarker strongly associated with MS and other metabolic indicators. This study aimed to investigate the relationship between serum asprosin levels and MS in PLWH. This prospective case\u2013control study enrolled 111 PLWH with MS and 111 PLWH without MS as controls. A 1:1 propensity score matching was performed to adjust for potential confounding factors, including age and antiretroviral therapy regimen. Serum asprosin levels and other clinical variables were measured. PLWH with MS exhibited significantly higher serum asprosin levels compared to those without MS (19.2 [14.2\u201324.4] vs 15.4 [11.4\u201318.1] ng\/mL, respectively,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Multivariate logistic regression analysis confirmed that elevated serum asprosin levels (odds ratios\u2005=\u20051.239, 95% confidence interval: 1.063\u20131.445,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006) were associated with MS in this population. Notably, the use of integrase strand transfer inhibitors was associated with the highest serum asprosin levels, followed by non-nucleoside reverse transcriptase inhibitors and protease inhibitors (17.8 [13.3\u201321.8] vs 16.6 [10.5\u201322.9] vs 16 [12, 18.7] ng\/mL, respectively,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006). Sensitivity analyses confirmed the robustness of the associations between serum asprosin levels and MS across different subgroups. Serum asprosin levels are significantly higher in PLWH with MS than those without. Additionally, the use of integrase strand transfer inhibitors was strongly associated with elevated serum asprosin levels. These findings provide novel clinical insights into the role of asprosin in the pathogenesis of MS in PLWH.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045373","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:00:14Z","timestamp":1762210814000},"page":"e45373","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between asprosin and metabolic syndrome in people living with human immunodeficiency virus: A case\u2013control study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8799-780X","authenticated-orcid":false,"given":"Yong","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Infection, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9465-5329","authenticated-orcid":false,"given":"Baolei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8584-4566","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","article-title":"Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges.","volume":"17","author":"Cao","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3947\/ic.2022.0061","article-title":"Weight gain and metabolic syndrome in human immunodeficiency virus patients.","volume":"54","author":"Chang","year":"2022","journal-title":"Infect Chemother"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1186\/s12889-024-20118-3","article-title":"Burden of metabolic syndrome in the global adult HIV-infected population: a systematic review and meta-analysis.","volume":"24","author":"Trachunthong","year":"2024","journal-title":"BMC Public Health"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-023-09815-4","article-title":"Human immunodeficiency virus as a risk factor for cardiovascular disease.","volume":"24","author":"Lembas","year":"2024","journal-title":"Cardiovasc Toxicol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11904-019-00467-0","article-title":"Contemporary lifestyle modification interventions to improve metabolic comorbidities in HIV.","volume":"16","author":"Fitch","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jn\/nxy241","article-title":"Diet quality is low and differs by sex in people with HIV.","volume":"149","author":"Weiss","year":"2019","journal-title":"J Nutr"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/QAD.0b013e32823644ff","article-title":"Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era.","volume":"21","author":"Joy","year":"2007","journal-title":"AIDS"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clnu.2013.07.004","article-title":"Optimal dietary calcium intake in HIV treated patients: no femoral osteoporosis but higher cardiovascular risk.","volume":"33","author":"Galli","year":"2014","journal-title":"Clin Nutr"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"12990","DOI":"10.1038\/srep12990","article-title":"High frequency of deficient consumption and low blood levels of 25-hydroxyvitamin D in HIV-1-infected adults from S\u00e3o Paulo city, Brazil.","volume":"5","author":"Sales","year":"2015","journal-title":"Sci Rep"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/09540121.2018.1441968","article-title":"Association of physical inactivity with hypertension and low educational level in people living with HIV\/AIDS.","volume":"30","author":"Silveira","year":"2018","journal-title":"AIDS Care"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3851\/IMP2998","article-title":"The effect of physical activity on cardiometabolic health and inflammation in treated HIV infection.","volume":"21","author":"Dirajlal-Fargo","year":"2016","journal-title":"Antivir Ther"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/09638288.2016.1260645","article-title":"Global physical activity levels among people living with HIV: a systematic review and meta-analysis.","volume":"40","author":"Vancampfort","year":"2018","journal-title":"Disabil Rehabil"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s10461-017-1715-8","article-title":"Physical activity is associated with metabolic health in men living with HIV.","volume":"22","author":"Forde","year":"2018","journal-title":"AIDS Behav"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12889-018-6386-5","article-title":"Focus groups inform a mobile health intervention to promote adherence to a Mediterranean diet and engagement in physical activity among people living with HIV.","volume":"19","author":"Henry","year":"2019","journal-title":"BMC Public Health"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jana.2014.01.003","article-title":"Barriers and facilitators to engagement in lifestyle interventions among individuals with HIV.","volume":"25","author":"Capili","year":"2014","journal-title":"J Assoc Nurses AIDS Care"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/v14081677","article-title":"Changes in body mass index after initiation of antiretroviral treatment: differences by class of core drug.","volume":"14","author":"Pantazis","year":"2022","journal-title":"Viruses"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jir.2024.0052","article-title":"Role of proinflammatory cytokines and genetic factors related to metabolic alterations in people living with HIV\/AIDS.","volume":"44","author":"Molina-Flores","year":"2024","journal-title":"J Interferon Cytokine Res"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"1514823","DOI":"10.3389\/fcimb.2025.1514823","article-title":"Development and validation of a nomogram for predicting the outcome of metabolic syndrome among people living with HIV after antiretroviral therapy in China.","volume":"15","author":"Jin","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/COH.0000000000000953","article-title":"Understanding residual risk of cardiovascular disease in people with HIV.","volume":"20","author":"Obare","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"102654","DOI":"10.1016\/j.jiph.2025.102654","article-title":"Cardiovascular disease and its risk factors among people living with HIV: a systematic review and meta-analysis.","volume":"18","author":"Du","year":"2025","journal-title":"J Infect Public Health"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1093\/infdis\/jiae532","article-title":"The primacy of adipose tissue gene expression and plasma lipidome in cardiometabolic disease in persons with HIV.","volume":"231","author":"Bailin","year":"2025","journal-title":"J Infect Dis"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/j.pbj.0000000000000108","article-title":"A state of the art review on the novel mediator asprosin in the metabolic syndrome.","volume":"5","author":"Lu\u00eds","year":"2020","journal-title":"Porto Biomed J"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/nu13020620","article-title":"Asprosin-A fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature.","volume":"13","author":"Mazur-Bialy","year":"2021","journal-title":"Nutrients"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"1407996","DOI":"10.3389\/fendo.2024.1407996","article-title":"Association between hypothyroidism and metabolic syndrome in Qinghai, China.","volume":"15","author":"Fan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China.","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"6622129","DOI":"10.1155\/2021\/6622129","article-title":"High serum asprosin levels are associated with presence of metabolic syndrome.","volume":"2021","author":"Hong","year":"2021","journal-title":"Int J Endocrinol"},{"key":"R27-20260915","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2021.211015","article-title":"Two important players for type 2 diabetes mellitus: Metrnl and asprosin.","volume":"68","author":"Timurkaan","year":"2022","journal-title":"Clin Lab"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","article-title":"Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.","volume":"489","author":"Zhang","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"9471583","DOI":"10.1155\/2018\/9471583","article-title":"Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion.","volume":"2018","author":"Wang","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.4432","article-title":"Asprosin is a centrally acting orexigenic hormone.","volume":"23","author":"Duerrschmid","year":"2017","journal-title":"Nat Med"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","article-title":"Serum asprosin levels and bariatric surgery outcomes in obese adults.","volume":"43","author":"Wang","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"7375294","DOI":"10.1155\/2018\/7375294","article-title":"Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases.","volume":"2018","author":"Li","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3855\/jidc.12519","article-title":"Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy.","volume":"16","author":"Zhang","year":"2022","journal-title":"J Infect Dev Ctries"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"635089","DOI":"10.3389\/fphar.2021.635089","article-title":"HIV protease inhibitors and insulin sensitivity: a systematic review and meta-analysis of randomized controlled trials.","volume":"12","author":"Kajogoo","year":"2021","journal-title":"Front Pharmacol"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0956462417732226","article-title":"Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and\/or metabolic syndrome in HIV-infected patients: a systematic review and meta-analysis.","volume":"29","author":"Echecopar-Sabogal","year":"2018","journal-title":"Int J STD AIDS"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0000000000002119","article-title":"Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors.","volume":"33","author":"Gelpi","year":"2019","journal-title":"AIDS"},{"key":"R37-20260915","first-page":"572","article-title":"Integrase strand transfer inhibitors, their impact in adipose tissue and weight gain in people living with HIV \u2013 a narrative review.","volume":"43","author":"Valle-Hern\u00e1ndez","year":"2025","journal-title":"Nutr Hosp"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a fasting-induced glucogenic protein hormone.","volume":"165","author":"Romere","year":"2016","journal-title":"Cell"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0000000000000616","article-title":"Weight gain and integrase inhibitors.","volume":"33","author":"Eckard","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1093\/cid\/ciaa259","article-title":"The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes.","volume":"71","author":"Gorwood","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:22Z","timestamp":1789499002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":40,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045373","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}